Patient-reported outcomes collected through an electronic health record-integrated symptom management program did not significantly reduce ED or inpatient admission events after cancer treatment, ...

CHICAGO -- Biomarker-driven adjuvant therapy for intermediate/high-risk non-small cell lung cancer (NSCLC) led to ...

Stephanie Walker was diagnosed with metastatic breast cancer (MBC) nearly a decade ago — an experience she says transformed ...

A new analysis suggests artificial intelligence algorithms are able to accurately assess lesion severity in patients with ...

A phase 2 trial found that adding bevacizumab to alectinib significantly delayed disease progression, protected against brain ...

Research has shown that a substantial portion of patients who are prescribed physical therapy fail to complete their ...

An extension trial revealed that long-term anifrolumab treatment improved health status and health-related quality of life in ...

The CISTO study is the only going prospective study comparing radical cystectomy vs bladder-sparing options for high-grade NMIBC.

Panelists discuss how patient-reported outcomes including symptom burden, treatment-related adverse effects, preserved functionality, and impact on quality of life should be prioritized alongside ...

Roughly 26% of patients with LN demonstrated a responsive and monophasic disease course, which was linked to older age and shorter SLE duration at LN onset.

The increased rate of venous thromboembolism among patients with chronic kidney disease (CKD) warrants increased clinical attention.